GC
CORZ icon

Gullane Capital’s Core Scientific CORZ Stock Holding History

Gullane Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35M Sell
2,338,849
-76,259
-3% -$1.3M 93.61% 1
2025
Q4 		$35.2M Sell
2,415,108
-880,871
-27% -$15.4M 94.14% 1
2025
Q3 		$59.1M Sell
3,295,979
-7,028,794
-68% -$103M 94.33% 1
2025
Q2 		$176M Buy
10,324,773
+285,897
+3% +$2.86M 93.61% 1
2025
Q1 		$72.7M Sell
10,038,876
-2,381,319
-19% -$27.1M 91.02% 1
2024
Q4 		$175M Buy
+12,420,195
New +$183M 76.75% 1

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Gullane Capital's CORZ Position: Q1 2026 in Review

Gullane Capital reduced its Core Scientific (CORZ) stake by 3.2% in Q1 2026, selling an estimated $1.3M and leaving 2,338,849 shares worth $35M. The position accounts for 93.61% of the portfolio, ranked #1.

Gullane Capital first reported a position in CORZ in Q4 2024 and has held it in 6 quarters since. The position peaked at $176M in Q2 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • Gullane Capital held 2,338,849 shares of Core Scientific worth $35M as of Q1 2026.
  • Gullane Capital sold 76,259 Core Scientific shares in Q1 2026, an estimated $1.3M.
  • Core Scientific made up 93.61% of Gullane Capital's portfolio in Q1 2026, its #1 holding.
  • Gullane Capital first reported a position in Core Scientific in Q4 2024 and has held it in 6 quarters since.
  • Gullane Capital's Core Scientific position peaked at $176M in Q2 2025.
  • 386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Gullane Capital's 13F filing for Q1 2026, filed 15 May 2026.